Bora Yildiz C, Du J, Mohan K, Zimmer-Bensch G, Abdolahi S
Epigenomics. 2025; 17(2):125-140.
PMID: 39829063
PMC: 11792803.
DOI: 10.1080/17501911.2024.2442297.
Bastola S, Pavlyukov M, Sharma N, Ghochani Y, Nakano M, Muthukrishnan S
Nat Commun. 2025; 16(1):471.
PMID: 39773984
PMC: 11707362.
DOI: 10.1038/s41467-024-55487-1.
Cirigliano S, Fine H
J Exp Med. 2024; 222(1).
PMID: 39626263
PMC: 11614461.
DOI: 10.1084/jem.20220808.
Dave B, Tailor J
BMC Cancer. 2024; 24(1):1465.
PMID: 39609728
PMC: 11603633.
DOI: 10.1186/s12885-024-13187-5.
Xie X, Ganbold M, Li J, Lien M, Chipman M, Wang T
Neuron. 2024; 112(24):4017-4032.e6.
PMID: 39510072
PMC: 11659040.
DOI: 10.1016/j.neuron.2024.10.012.
Deciphering the topological landscape of glioma using a network theory framework.
Yao M, Su Y, Xiong R, Zhang X, Zhu X, Chen Y
Sci Rep. 2024; 14(1):26724.
PMID: 39496747
PMC: 11535471.
DOI: 10.1038/s41598-024-77856-y.
HOXDeRNA activates a cancerous transcription program and super enhancers via genome-wide binding.
Deforzh E, Kharel P, Zhang Y, Karelin A, El Khayari A, Ivanov P
Mol Cell. 2024; 84(20):3950-3966.e6.
PMID: 39383879
PMC: 11490371.
DOI: 10.1016/j.molcel.2024.09.018.
Multi-modal fusion and feature enhancement U-Net coupling with stem cell niches proximity estimation for voxel-wise GBM recurrence prediction.
Jiao C, Lao Y, Zhang W, Braunstein S, Salans M, Villanueva-Meyer J
Phys Med Biol. 2024; 69(15).
PMID: 39019073
PMC: 11308744.
DOI: 10.1088/1361-6560/ad64b8.
In vivo mouse models for adult brain tumors: Exploring tumorigenesis and advancing immunotherapy development.
Figg J, Chen D, Font L, Flores C, Jin D
Neuro Oncol. 2024; 26(11):1964-1980.
PMID: 38990913
PMC: 11534310.
DOI: 10.1093/neuonc/noae131.
Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model.
Alberti G, Amico M, Caruso Bavisotto C, Rappa F, Marino Gammazza A, Bucchieri F
Int J Mol Sci. 2024; 25(10).
PMID: 38791432
PMC: 11121320.
DOI: 10.3390/ijms25105394.
Glioblastoma modeling with 3D organoids: progress and challenges.
Wang X, Sun Y, Zhang D, Ming G, Song H
Oxf Open Neurosci. 2024; 2:kvad008.
PMID: 38596241
PMC: 10913843.
DOI: 10.1093/oons/kvad008.
CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle.
Zhou H, Wang Y, Wang T, Wu W, Cao Y, Zhang B
Oncol Lett. 2024; 27(5):206.
PMID: 38516683
PMC: 10956385.
DOI: 10.3892/ol.2024.14339.
A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs.
Wang C, Sun M, Shao C, Schlicker L, Zhuo Y, Harim Y
NPJ Precis Oncol. 2024; 8(1):19.
PMID: 38273014
PMC: 10811239.
DOI: 10.1038/s41698-024-00500-5.
Alterations in and are associated with the localization of contrast-enhancing lesions in glioblastoma.
Makino R, Higa N, Akahane T, Yonezawa H, Uchida H, Takajo T
Neurooncol Adv. 2023; 5(1):vdad110.
PMID: 37744696
PMC: 10516461.
DOI: 10.1093/noajnl/vdad110.
Management and Molecular Characterization of Intraventricular Glioblastoma: A Single-Institution Case Series.
Parker M, Kalluri A, Materi J, Gujar S, Schreck K, Mukherjee D
Int J Mol Sci. 2023; 24(17).
PMID: 37686092
PMC: 10488126.
DOI: 10.3390/ijms241713285.
Molecular and clonal evolution reveal a common pathway of distant relapse gliomas.
Liu G, Bu C, Guo G, Zhang Z, Sheng Z, Deng K
iScience. 2023; 26(9):107528.
PMID: 37649695
PMC: 10462858.
DOI: 10.1016/j.isci.2023.107528.
Dissecting Intra-tumor Heterogeneity in the Glioblastoma Microenvironment Using Fluorescence-Guided Multiple Sampling.
Garcia-Montano L, Licon-Munoz Y, Martinez F, Keddari Y, Ziemke M, Chohan M
Mol Cancer Res. 2023; 21(8):755-767.
PMID: 37255362
PMC: 10390891.
DOI: 10.1158/1541-7786.MCR-23-0048.
Neural Stem Cells as Potential Glioblastoma Cells of Origin.
Loras A, Gonzalez-Bonet L, Gutierrez-Arroyo J, Martinez-Cadenas C, Marques-Torrejon M
Life (Basel). 2023; 13(4).
PMID: 37109434
PMC: 10145968.
DOI: 10.3390/life13040905.
Trametinib in Patients With , , or -Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2.
Wisinski K, Flamand Y, Wilson M, Luke J, Tawbi H, Hong F
JCO Precis Oncol. 2023; 7:e2200421.
PMID: 37053535
PMC: 10309549.
DOI: 10.1200/PO.22.00421.
Loss of p53 Concurrent with RAS and TERT Activation Induces Glioma Formation.
Gong M, Fan X, Yu H, Niu W, Sun S, Wang H
Mol Neurobiol. 2023; 60(6):3452-3463.
PMID: 36867344
DOI: 10.1007/s12035-023-03288-w.